Aging and Neurodegeneration Review Branch – AN
Dr. Wei-Qin Zhao
Chief
Review Branch Summary
The Aging and Neurodegeneration (AN) Review Branch reviews basic, applied, and clinical grant applications on human aging (geriatric and late-life disorders involving multiple organ systems), neurodegenerative diseases, and neurocognitive disorders (examining the cellular and molecular aspects of neurodegeneration at the mechanistic level, or using animal model experimental approaches or human-subject based studies to address the mechanisms, etiology, pathogenesis and management of these diseases and disorders). These neurodegenerative diseases and neurocognitive disorders include Alzheimer’s disease (AD) and Alzheimer's disease-related dementias (ADRD); other dementias including mild cognitive impairment (MCI), dementia with Lewy bodies, frontotemporal lobe dementia (FTLD) and vascular contributions to cognitive impairment and dementia (VCID); Parkinson’s disease (PD) and other movement disorders (Huntington’s disease (HD), dystonia, dyskinesia, and ataxias); and Amyotrophic Lateral Sclerosis (ALS) and related motor neuron disorders.
Study Sections
- Aging Systems and Geriatrics Study Section ASG
- New! Cognitive Disorder and Brain Aging Study Section*Starts with January 2025 council round submission deadline CDBA
- Chronic Dysfunction and Integrative Neurodegeneration Study Section CDIN
- Cellular and Molecular Biology of Neurodegeneration Study Section CMND
- Clinical Neuroscience and Neurodegeneration Study Section *Ends after October 2024 council round meetings CNN
- Clinical Neurodegeneration Translational Neuroscience*Starts with January 2025 council round submission deadline CNTN
- New! Drug Discovery for Aging, Neuropsychiatric and Neurologic Disorders Small Business SEP AN (11)
- Behavioral Neuroscience Fellowship Study Section *Ends after February/March 2023 review meetings F02A
